Skip to content

13F-HR filed by Palo Alto Investors LP

Palo Alto Investors LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:36:59 UTC, with 56 holding rows worth $672,150,352.

Accession
0002073679-26-000180
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 56 entries on the cover page, a total value of $672,150,352 stated on the cover page (in dollars after the unit check, H1), rows summing to $672,150,352 with VALUE read as dollars as filed, 13F file number 028-11013. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PTC THERAPEUTICS INC69366J200COM875,349$56,705,108dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM3,471,456$51,446,978dollars as filed
INSMED INC COM PAR $.01457669307Stock443,645$50,637,640dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM2,485,608$50,085,001dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM642,455$38,547,300dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM387,314$33,107,601dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock58,875$31,903,774dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock1,881,927$30,317,844dollars as filed
BIOGEN INC COM09062X103Stock132,918$30,023,518dollars as filed
ANAPTYSBIO INC032724106COM595,264$29,917,969dollars as filed
CAREDX INC14167L103COM424,601$27,599,065dollars as filed
FIRST TRACKS BIOTHERAPEUTICS337185102ORD SHS *A*741,097$26,264,478dollars as filed
DISC MEDICINE INC COM254604101Stock396,529$25,956,788dollars as filed
NOVOCURE LTDG6674U108ORD SHS1,209,774$19,295,895dollars as filed
BICARA THERAPEUTICS INC055477103COM689,344$12,828,692dollars as filed
ANNEXON INC03589W102COM2,811,222$11,891,469dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM596,356$11,211,493dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW343,101$11,119,903dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM710,029$10,671,736dollars as filed
PROTHENA CORP PLC SHSG72800108Stock1,129,363$9,464,062dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM158,946$9,358,740dollars as filed
ALKERMES PLCG01767105SHS203,680$8,253,114dollars as filed
COMPASS THERAPEUTICS INC20454B104COM7,148,673$7,434,620dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM200,984$6,682,718dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK1,337,217$6,512,247dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock1,156,396$6,082,643dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK548,071$5,190,232dollars as filed
ALIGN TECHNOLOGY INC COM016255101Stock31,389$4,562,391dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK162,874$3,961,096dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK1,035,964$3,159,690dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock220,226$2,955,433dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock33,640$2,903,805dollars as filed
VERASTEM INC92337C203COMMON STOCK325,480$2,620,114dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM18,117$2,569,715dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK250,000$2,470,000dollars as filed
Adlai Nortye00704R109SPONSORED ADS149,490$2,391,840dollars as filed
STOKE THERAPEUTICS INC86150R107COM84,631$2,200,406dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock25,563$2,129,142dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock36,949$2,044,019dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock864,277$2,013,765dollars as filed
CYTOKINETICS INC23282W605COM NEW30,036$1,979,673dollars as filed
BIONTECH SE SPONSORED ADS09075V102ADR19,614$1,928,056dollars as filed
NUVATION BIO INC COM CL A67080N101Stock326,609$1,829,010dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock47,902$1,781,475dollars as filed
HUMANA INC COM444859102Stock3,985$1,520,556dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS115,616$1,438,263dollars as filed
EHEALTH INC28238P109COM1,431,535$1,016,390dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM104,410$998,160dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK24,500$995,435dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock1,787$900,577dollars as filed
CYBIN INC23256X407COM NEW72,634$892,672dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS188,351$693,132dollars as filed
INSPIRE MED SYS INC COM457730109Stock8,772$608,426dollars as filed
ABEONA THERAPEUTICS INC00289Y206COM NEW108,865$571,541dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO188,807$313,420dollars as filed
ALDEYRA THERAPEUTICS INC01438T106COM155,709$191,522dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002073679-26-000180this filing2026-11-16